The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, held a meeting today, Sunday, with several presidents and representatives from food, drug, and medical device companies at the SFDA headquarters in Jeddah.

The discussions focused on strategic topics aimed at developing the food, drug, and medical device sectors, streamlining regulatory procedures, and elevating compliance with approved regulations and standards. The overarching goal was to strengthen the investment environment across these vital fields.

Dr. Aljadhey emphasized the critical importance of sustaining constructive communication with companies. He stressed the need to proactively incorporate industry views and proposals to optimize Saudi Arabia’s investment climate. This approach, he noted, is essential for achieving the highest standards of safety and quality, ensuring sector sustainability, and ultimately providing consumers with safe and effective products. Dr. Aljadhey further affirmed SFDA’s unwavering commitment to exerting every effort to guarantee that.

Following the industry session, Dr. Aljadhey met with citizens who benefit from the Authority’s services. He attentively reviewed their comments and suggestions, reaffirming SFDA's dedication to enhancing the beneficiary experience, developing services to align with societal expectations, and enhancing overall transparency and quality of performance.